Last 12 months
Inside the activity.
6 purchase rows · 11 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 1 | 0 |
| Feb 2026 | 2 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 2 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 08, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 24,247 | $42.83 | $1,038,499.01 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · nonDerivative · entry 5 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,196 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
Exercise / conversionCommon shares without par value | 72,130 | $42.50 | $3,065,366.31 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · nonDerivative · entry 4 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2007 Filed Aug 10, 2007 20:46 UTC |
Michael Edward L.Executive Vice President
|
GrantOption (right to buy) · Derivative | 31,045 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061448 · a4.xml · derivative · entry 5 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,045 Underlying: Common Shares · 31,045 shares Expires 2008-02-12 F1 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 10, 2007 20:46 UTC |
Michael Edward L.Executive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 39,687 | $0.00 Strike: $34.77 | $0.00 |
DisclosureSEC source: 0001104659-07-061448 · a4.xml · derivative · entry 4 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,875 Underlying: Common Shares · 39,687 shares Expires 2008-02-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Employee stock option, including replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 10, 2007 20:46 UTC |
Michael Edward L.Executive Vice President
|
SaleCommon shares without par value | 8,642 | $55.79 | $482,111.25 |
DisclosureSEC source: 0001104659-07-061448 · a4.xml · nonDerivative · entry 3 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,331 Read SEC document |
| August 08, 2007 Filed Aug 10, 2007 20:46 UTC |
Michael Edward L.Executive Vice President
|
Tax withholdingCommon shares without par value | 31,045 | $54.30 | $1,685,743.50 |
DisclosureSEC source: 0001104659-07-061448 · a4.xml · nonDerivative · entry 2 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,973 Read SEC document |
| August 08, 2007 Filed Aug 10, 2007 20:46 UTC |
Michael Edward L.Executive Vice President
|
Exercise / conversionCommon shares without par value | 39,687 | $34.77 | $1,380,024.14 |
DisclosureSEC source: 0001104659-07-061448 · a4.xml · nonDerivative · entry 1 Michael Edward L · CIK 0001391823 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2007 Filed Aug 10, 2007 23:21 UTC |
FREYMAN THOMAS CExecutive Vice President
|
GrantOption (right to buy) · Derivative | 16,384 | $0.00 Strike: $54.30 | $0.00 |
DisclosureSEC source: 0001104659-07-061521 · a4.xml · derivative · entry 10 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,384 Underlying: common shares · 16,384 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 10, 2007 23:21 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 19,507 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-061521 · a4.xml · derivative · entry 9 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 19,507 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3. Read SEC document |
| August 08, 2007 Filed Aug 10, 2007 23:21 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Tax withholdingCommon shares without par value | 16,384 | $54.30 | $889,651.20 |
DisclosureSEC source: 0001104659-07-061521 · a4.xml · nonDerivative · entry 2 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,199 Read SEC document |
| August 08, 2007 Filed Aug 10, 2007 23:21 UTC |
FREYMAN THOMAS CExecutive Vice President
|
Exercise / conversionCommon shares without par value | 19,507 | $41.03 | $800,405.37 |
DisclosureSEC source: 0001104659-07-061521 · a4.xml · nonDerivative · entry 1 FREYMAN THOMAS C · CIK 0001239126 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 292,583 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 8, 2007 22:05 UTC |
Schumacher Laura JExecutive Vice President
|
GrantOption (right to buy) · Derivative | 625 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-060342 · a4.xml · derivative · entry 8 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625 Underlying: Common shares · 625 shares Expires 2010-02-10 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 8, 2007 22:05 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 2,440 | $0.00 Strike: $41.22 | $0.00 |
DisclosureSEC source: 0001104659-07-060342 · a4.xml · derivative · entry 7 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 2,440 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 8, 2007 22:05 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 3,997 | $0.00 Strike: $41.00 | $0.00 |
DisclosureSEC source: 0001104659-07-060342 · a4.xml · derivative · entry 6 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 3,997 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 8, 2007 22:05 UTC |
Schumacher Laura JExecutive Vice President
|
SaleCommon shares without par value | 5,812 | $54.46 | $316,520.94 |
DisclosureSEC source: 0001104659-07-060342 · a4.xml · nonDerivative · entry 4 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,524 Read SEC document |
| August 07, 2007 Filed Aug 8, 2007 22:05 UTC |
Schumacher Laura JExecutive Vice President
|
Tax withholdingCommon shares without par value | 625 | $53.12 | $33,200.00 |
DisclosureSEC source: 0001104659-07-060342 · a4.xml · nonDerivative · entry 3 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,336 Read SEC document |
| August 07, 2007 Filed Aug 8, 2007 22:05 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 2,440 | $41.22 | $100,576.07 |
DisclosureSEC source: 0001104659-07-060342 · a4.xml · nonDerivative · entry 2 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 8, 2007 22:05 UTC |
Schumacher Laura JExecutive Vice President
|
Exercise / conversionCommon shares without par value | 3,997 | $41.00 | $163,877.00 |
DisclosureSEC source: 0001104659-07-060342 · a4.xml · nonDerivative · entry 1 Schumacher Laura J · CIK 0001319245 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,521 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 20:47 UTC |
Fussell Stephen RSenior Vice President
|
GrantOption (right to buy) · Derivative | 5,816 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-060981 · a4.xml · derivative · entry 5 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,816 Underlying: common shares · 5,816 shares Expires 2014-02-19 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 20:47 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 6,746 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-060981 · a4.xml · derivative · entry 4 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,854 Underlying: common shares · 6,746 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 20:47 UTC |
Fussell Stephen RSenior Vice President
|
Tax withholdingCommon shares without par value | 5,816 | $53.12 | $308,945.92 |
DisclosureSEC source: 0001104659-07-060981 · a4.xml · nonDerivative · entry 2 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,382 Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 20:47 UTC |
Fussell Stephen RSenior Vice President
|
Exercise / conversionCommon shares without par value | 6,746 | $41.03 | $276,799.85 |
DisclosureSEC source: 0001104659-07-060981 · a4.xml · nonDerivative · entry 1 Fussell Stephen R · CIK 0001327700 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,198 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 11,177 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 20 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,177 Underlying: common shares · 11,177 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 13,528 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 19 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,528 Underlying: common shares · 13,528 shares Expires 2013-02-13 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 84 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 18 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84 Underlying: common shares · 84 shares Expires 2010-02-10 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
GrantOption (right to buy) · Derivative | 7,057 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 17 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,057 Underlying: common shares · 7,057 shares Expires 2014-02-19 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 12,804 | $0.00 Strike: $41.97 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 14 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 12,804 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 15,585 | $0.00 Strike: $41.54 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 13 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 15,585 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 98 | $0.00 Strike: $41.14 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 12 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: common shares · 98 shares Expires 2010-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 8,185 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · derivative · entry 11 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,454 Underlying: common shares · 8,185 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Tax withholdingCommon shares without par value | 31,846 | $53.12 | $1,691,659.52 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · nonDerivative · entry 5 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,700 Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 12,804 | $41.97 | $537,403.09 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · nonDerivative · entry 4 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,546 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 15,585 | $41.54 | $647,388.43 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · nonDerivative · entry 3 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,742 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 98 | $41.14 | $4,032.16 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · nonDerivative · entry 2 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,157 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:06 UTC |
Chen Thomas FSenior Vice President
|
Exercise / conversionCommon shares without par value | 8,185 | $41.03 | $335,844.46 |
DisclosureSEC source: 0001104659-07-061021 · a4.xml · nonDerivative · entry 1 Chen Thomas F · CIK 0001360147 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 4,935 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 13 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,935 Underlying: Common shares · 4,935 shares Expires 2013-02-13 F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
GrantOption (right to buy) · Derivative | 7,057 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 12 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,057 Underlying: Common shares · 7,057 shares Expires 2014-02-19 F5 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 5,621 | $0.00 Strike: $42.42 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 11 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 5,621 shares Expires 2013-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · security: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 8,185 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · derivative · entry 10 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,454 Underlying: Common shares · 8,185 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · security: Employee stock option including a replacement option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Tax withholdingCommon shares without par value | 11,992 | $53.12 | $637,015.04 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · nonDerivative · entry 3 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,366 Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 5,621 | $42.42 | $238,442.82 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · nonDerivative · entry 2 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:27 UTC |
Landgraf John CSenior Vice President
|
Exercise / conversionCommon shares without par value | 8,185 | $41.03 | $335,844.46 |
DisclosureSEC source: 0001104659-07-061057 · a4.xml · nonDerivative · entry 1 Landgraf John C · CIK 0001298968 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:31 UTC |
Bohuon OlivierSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 7,179 | $0.00 Strike: $41.78 | $0.00 |
DisclosureSEC source: 0001104659-07-061065 · a4.xml · derivative · entry 7 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 7,179 shares Expires 2013-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to Abbott Laboratories Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:31 UTC |
Bohuon OlivierSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 31,920 | $0.00 Strike: $41.03 | $0.00 |
DisclosureSEC source: 0001104659-07-061065 · a4.xml · derivative · entry 6 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common shares · 31,920 shares Expires 2014-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to Abbott Laboratories Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:31 UTC |
Bohuon OlivierSenior Vice President
|
Exercise / conversionOption (right to buy) · Derivative | 12,000 | $0.00 Strike: $41.78 | $0.00 |
DisclosureSEC source: 0001104659-07-061065 · a4.xml · derivative · entry 5 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,023 Underlying: Common shares · 12,000 shares Expires 2013-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Employee stock option, including replacement option feature granted pursuant to Abbott Laboratories Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:31 UTC |
Bohuon OlivierSenior Vice President
|
SaleCommon shares without par value | 51,099 | $55.00 | $2,810,445.00 |
DisclosureSEC source: 0001104659-07-061065 · a4.xml · nonDerivative · entry 4 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,664 Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:31 UTC |
Bohuon OlivierSenior Vice President
|
Exercise / conversionCommon shares without par value | 31,920 | $41.03 | $1,309,731.86 |
DisclosureSEC source: 0001104659-07-061065 · a4.xml · nonDerivative · entry 3 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:31 UTC |
Bohuon OlivierSenior Vice President
|
Exercise / conversionCommon shares without par value | 19,179 | $41.78 | $801,367.66 |
DisclosureSEC source: 0001104659-07-061065 · a4.xml · nonDerivative · entry 2 Bohuon Olivier · CIK 0001360215 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantOption (right to buy) · Derivative | 9,566 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · derivative · entry 11 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,566 Underlying: Common shares · 9,566 shares Expires 2013-02-13 F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
| August 07, 2007 Filed Aug 9, 2007 21:48 UTC |
DEMPSEY WILLIAM GExecutive Vice President
|
GrantOption (right to buy) · Derivative | 14,703 | $0.00 Strike: $53.12 | $0.00 |
DisclosureSEC source: 0001104659-07-061073 · a4.xml · derivative · entry 10 DEMPSEY WILLIAM G · CIK 0001239422 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,703 Underlying: Common shares · 14,703 shares Expires 2014-02-19 F2 · security: Employee stock option, including replacement option feature granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16(b) under Rule 16b-3. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.